LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 15.58 | 27.76 | 133 | 685 | 0.1940 | 0.4031 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 15.58 | 27.76 | 925 | 685 | 1.3492 | 1.1338 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 15.58 | 27.76 | 19 | 685 | 0.0277 | -0.0787 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 15.58 | 27.76 | 1299 | 685 | 1.8948 | 1.2963 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.28 | 27.76 | 466 | 838 | 0.5556 | 0.7747 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.28 | 27.76 | 989 | 838 | 1.1792 | 1.0682 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.28 | 27.76 | 26 | 838 | 0.0310 | -0.0132 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.28 | 27.76 | 1378 | 838 | 1.6430 | 1.2125 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.98 | 27.76 | 671 | 941 | 0.7130 | 0.8712 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.98 | 27.76 | 1103 | 941 | 1.1720 | 1.0634 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.98 | 27.76 | 43 | 941 | 0.0457 | 0.0899 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.98 | 27.76 | 1536 | 941 | 1.6321 | 1.2023 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.68 | 27.76 | 1091 | 1119 | 0.9750 | 0.9905 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.68 | 27.76 | 1250 | 1119 | 1.1171 | 1.0420 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.68 | 27.76 | 70 | 1119 | 0.0626 | 0.1894 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.68 | 27.76 | 1662 | 1119 | 1.4853 | 1.1540 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.39 | 27.76 | 1258 | 1305 | 0.9635 | 0.9866 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.39 | 27.76 | 1348 | 1305 | 1.0324 | 1.0115 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.39 | 27.76 | 98 | 1305 | 0.0751 | 0.2549 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.39 | 27.76 | 1785 | 1305 | 1.3671 | 1.1158 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.09 | 27.76 | 1378 | 1461 | 0.9428 | 0.9795 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.09 | 27.76 | 1449 | 1461 | 0.9914 | 0.9970 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.09 | 27.76 | 105 | 1461 | 0.0718 | 0.2619 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.09 | 27.76 | 1964 | 1461 | 1.3437 | 1.1060 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.79 | 27.76 | 1494 | 1605 | 0.9308 | 0.9756 | MN20160318_Q01 | D09 |